HomeQuestion

How do you typically approach adjuvant therapy for a Masaoka stage IVa thymoma post-R0 resection?

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

How would you treat a patient with metastatic NSCLC, adenocarcinoma subtype with BRAF V600K mutation, PD-L1 >50% with progression on 1st line chemo-immunotherapy?

Would you give durvalumab consolidation to a patient with stage III NSCLC with an STK11 mutation?

For the neoadjuvant treatment for thymoma, when do you favor CAP with prednisone over CAP?

Is there evidence supporting the role of SBRT in the management of oligometastatic stage IV NSCLC?

How do you counsel eligible patients on lung cancer screening who are hesitant because of the cancer risk from CT scans?

Evidence Meets Expertise

For Physicians

Mednet AI
Community

Company

About
Careers
Publications
Blog

Support

FAQs
Code of Conduct
AI Community Guidelines
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.